Search

297 Result(s)
Sort by

Innovation Through Cooperation

Innovation Through Cooperation

Exchange of information between pharmaceutical manufacturers and healthcare professionals is essential for patients. Click here to learn more.
From Idea to Drug

From Idea to Drug

Development of a new drug starts with the hunt for effective compounds and finishes with the approval of the drug. Click here to learn more.
History of the logo
The logo used by Boehringer Ingelheim today is a stylised depiction of the central section of the imperial palace of Charlemagne. Learn more here.
COVID-19: EFPIA Industry Information

COVID-19: EFPIA Industry Information

The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
Waste

Waste

Resource conservation at Boehringer Ingelheim is managed as part of an ongoing process of prevention and reduction of material usage and waste. Learn more.
Speak up

Speak up

We are committed to conducting business with integrity and in compliance with applicable laws, regulations, company policies and procedures. Find out more.
Human Health

Human Health

Boehringer Ingelheim is dedicated to the discovery, development, manufacture and marketing of innovative health care products. Click here to learn more.
Ridgefield

Ridgefield

Learn more about Ridgefield, the home of Boehringer Ingelheim's US headquarters. The site serves as a key research centre for human pharmaceuticals.
Management Systems

Management Systems

Suppliers shall use management systems to support continuous improvement and compliance with the supplier code of conduct. Click here to learn more.
Labor & Human Rights

Labor & Human Rights

Suppliers shall support and respect the protection of internationally proclaimed human rights. Click here to read and find out more information.
Social Support

Social Support

People living with cancer share their diagnosis stories and perspectives on the importance of social support. Click here to find out and learn more.
COVID-19 Volunteering in Wuhan China

COVID-19 Volunteering in Wuhan China

Boehringer Ingelheim is striving to support community residents and the Wuhan community during this epidemic. Click here to find out and learn more.
Collaborating with RDA in the UK

Collaborating with RDA in the UK

The Riding for the Disabled Association (RDA) provides therapy, achievement and enjoyment to people with disabilities all over the UK. Learn more here.
Improving Access to Stroke Care

Improving Access to Stroke Care

Boehringer Ingelheim’s Angels Initiative is featured as a Best Practice example by the Access to Medicine Initiative. Click here to find out more.
COVID-19 Bill and Melinda Gates Foundation

COVID-19 Bill and Melinda Gates Foundation

We are joining the COVID-19 Therapeutics Accelerator of the Bill and Melinda Gates Foundation to fight the pandemic. Click here to learn more.
COVID-19: Research Update

COVID-19: Research Update

Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
COVID-19 COVID-19 Southeast Asia Donations

COVID-19 COVID-19 Southeast Asia Donations

Beyond direct support of the healthcare community on the ground, several organisations are receiving support in Southeast Asia & South Korea. Learn more.
Ethical Business Practices

Ethical Business Practices

Suppliers shall conduct their business in an ethical manner and act with integrity. Click here to read the supplier code of conduct and learn more.
Boehringer Ingelheim - Value Through Innovation

Boehringer Ingelheim - Value Through Innovation

Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here to learn more.